MSB 4.69% $1.45 mesoblast limited

Cell Therapy News/Articles, page-187

  1. wot
    10,366 Posts.
    lightbulb Created with Sketch. 1472
    In addition to the strategic alliance with Tasly, Mesoblast is in advanced negotiations with selected
    pharmaceutical companies with respect to potential partnering of certain Tier 1 product candidates.

    This stock is a no brainer. Tick Tick Tick.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.